Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kirk Look Insider Profile
4 Followers
Kirk Look, Chief Financial Officer at Oncolytics Biotech, holds 75.13K shares in Oncolytics Biotech (Ticker: ONCY).
Kirk Look Oncolytics Biotech (ONCY)Chief Financial Officer
Oncolytics Biotech (ONCY)
Chief Financial Officer
Ranked #12,339 out of 99,797 Corporate Insiders
Profitable Transactions
4 out of 6 Profitable Transactions
Average Return
+23.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Financial Officer
Roles that Kirk Look holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 15, 2022 - Jun 15, 2023
Return:+116.60%
The most profitable trade made by Kirk Look
Kirk Look's Trading History
List of latest transactions for each holding click on a transaction to see Kirk Look's performance on stock
You May Also Like
Kirk Look insider profile FAQ
What is the percentage of profitable transactions made by Kirk Look?
The percentage of profitable transactions made by Kirk Look is 67%.
What is the average return per transaction made by Kirk Look?
The average return per transaction made by Kirk Look is 23.70%.
What stocks does Kirk Look hold?
Kirk Look holds: ONCY stocks.
What was Kirk Look’s latest transaction?
Kirk Look latest transaction was an Uninformative Sell of ―.
What was Kirk Look's most profitable transaction?
Kirk Look’s most profitable transaction was an Informative Buy of ONCY stock on June 15, 2022. The return on the trade was 116.60%.
What is Kirk Look's role in Oncolytics Biotech?
Kirk Look's role in Oncolytics Biotech is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.